{
    "code": "02024886",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024886",
    "time": "2023-12-21 19:36:08",
    "許可證字號": "衛署藥輸字第024886號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/09\/11",
    "發證\/登錄日期": "97\/09\/11",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202488602",
    "中文品名": "思樂康持續性藥效錠 300 毫克",
    "英文品名": "Seroquel XR TM 300 mg Extended-Release Tablets",
    "適應症": "治療思覺失調症、雙極性疾患的鬱症發作、躁症發作或混合發作。對於抗鬱劑單一藥物治療效果不佳的重鬱症(MDD)病人，可作為重鬱症發作的附加治療。開始治療之前，臨床醫師應該考慮seroquel XR的安全性。",
    "劑型": "164持續性藥效膜衣錠",
    "包裝": "2~1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "QUETIAPINE FUMARATE",
    "限制項目": "02輸　入 5A本品係依本署93年05月05日衛署藥字第0930309777號公告經本署認定得免除銜接性試驗，且經本署核定之新藥",
    "申請商名稱": "吉富貿易有限公司",
    "申請商地址": "臺北市內湖區行愛路77巷69號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "ASTRAZENECA PHARMACEUTICALS LP",
            "製造廠廠址": "587 OLD BALTIMORE PIKE,NEWARK, DE 19702, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "ASTRAZENECA UK LIMITED",
            "製造廠廠址": "SILK ROAD BUSINESS PARK,MACCLESFIELD,CHESHIRE,SK10 2NA",
            "製造廠公司地址": "ALDERLEY PARK MACCLESFIELD CHESHIRE SK 10 4TF",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037620",
            "成分名稱": "QUETIAPINE FUMARATE",
            "含量描述": "",
            "含量": "345.3800000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "膠囊狀膜衣錠",
        "特殊劑型": "",
        "顏色": "淡黃色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Seroquel XR Tablets 300mg - 024886 - Tablet-104-10-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024886&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "110031117-p1-leaflet50,200,300mg-112-11-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024886&Seq=015&Type=9"
        },
        {
            "title": "Seroquel XR 50mg, 200mg, 300mg Tablets 中文仿單核定本-Rhabdomyolysis and Confusional state-110-12-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024886&Seq=014&Type=9"
        },
        {
            "title": "Seroquel XR 300mg-鋁箔-P042494-108-05-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024886&Seq=004&Type=8"
        },
        {
            "title": "Seroquel XR 300mg-外盒-P037560-108-05-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024886&Seq=003&Type=8"
        },
        {
            "title": "Seroquel XR Tablets 300mg - 024886 - Foil-104-10-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024886&Seq=002&Type=8"
        }
    ]
}